Search

Search Constraints

You searched for: Author/Creator Johnson, Keith A.

Search Results

221. Plasma Biomarkers of Neurodegeneration and Tau in Relation to Longitudinal Depressive Symptoms in Older Adults: Findings from the Harvard Aging Brain Study. (20th December 2022)

222. Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively normal older adults: Biomarkers (non‐neuroimaging)/Plasma/Serum/Urine biomarkers. (7th December 2020)

223. Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively unimpaired older adults. Issue 4 (23rd June 2021)

224. Plasma levels of an N‐terminal tau fragment are highly associated with future cognitive decline and neurodegeneration in clinically normal elderly: Biomarkers (non‐neuroimaging): Blood based biomarkers. (7th December 2020)

225. Plasma levels of an N‐terminal tau fragment predict core AD and neurodegenerative biomarkers in autosomal dominant Alzheimer's disease: Findings from DIAN. (20th December 2022)

226. Plasma ptau231 predicts locus coeruleus integrity earlier in life than other Alzheimer's disease plasma markers: a 7T MRI study across the adult lifespan. (20th December 2022)

227. Predictive value of visually rated tau PET imaging for amyloid status, atrophy, and syndromic diagnosis across a spectrum of neurodegenerative phenotypes: Neuroimaging / differential diagnosis. (7th December 2020)

228. Progressive white matter injury in autosomal dominant Alzheimer's disease is strongly associated with cerebral microbleeds and neurodegeneration. (20th December 2022)

229. Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy. Issue 3 (25th June 2022)

230. Rate‐limiting processes of tau aggregate accumulation in Alzheimer's disease. (1st February 2022)